Preparation of in-vivo tissue-engineered valved conduit with the sinus of valsalva (type IV biovalve)

Journal of Artificial Organs

Volumn 13, Issue 2, 2010, Pages 106-112

  Yamanami, Masashi ^a,b   Yahata, Yuki ^c   Tajikawa, Tsutomu ^c   Ohba, Kenkichi ^c   Watanabe, Taiji ^a,b   Kanda, Keiichi ^b   Yaku, Hitoshi ^b   Nakayama, Yasuhide ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c KANSAI UNIVERSITY   (Japan)

Author keywords

Autologous valve; Biovalve; In vivo tissue engineering; Sinus of Valsalva

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA SINUS; ARTICLE; BIOREACTOR; CONTROLLED STUDY; HEART FUNCTION; HEART VALVE BIOPROSTHESIS; IN VIVO CULTURE; NONHUMAN; PRIORITY JOURNAL; PULSATILE FLOW; RABBIT; TISSUE ENGINEERING; ANIMAL; BIOPROSTHESIS; HEART VALVE PROSTHESIS; PROSTHESIS; SURGERY; TISSUE SCAFFOLD;

ANIMALS; BIOPROSTHESIS; HEART VALVE PROSTHESIS; PROSTHESIS DESIGN; RABBITS; SINUS OF VALSALVA; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 77956467144     PISSN: 14347229     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10047-010-0491-2     Document Type: Article

References (23)

1. Vongpatanasin W, Hillis D, Lange RA. Prosthetic heart valves. N Engl J Med. 1996;335:407-16.
2. Bloomfield P, Wheatley DJ, Prescott RJ, Miller HC. Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med. 1991;324:573-9.
3. Hammermeister KE, Sethi GK, Henderson WG, Oprian C, Kim T, Rahimtoola S. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve of bioprosthesis. N Engl J Med. 1993;328:1289-96.
4. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation. 1994;89:635-41.
5. Ozaki S, Herijgers P, Flameng W. Influence of blood contact on the calcification of glutaraldehyde-pretreated aortic valves. Cardiovasc Surg. 2003;9:245-52.
6. Grunlemeier GL, Jamieson WRE, Miller DC, Starr A. Actuarial versus actual risk of porcine structural valve deterioration. J Thorac Cardiovasc Surg. 1994;108:709-18.
7. Cosgrove DM, Lytle BW, Taylor PC, Camacho MT, Stewart RW, McCarthy PM, et al. The Carpentir-Edwards pericardial aortic valve: ten-year results. J Thorac Cardiovasc Surg. 1995;110:651-62.
8. Steinhoff G, Stock U, Karim N, Mertsching H, Timke A, Meliss RR, et al. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation. 2000;102:III50-5.
9. Shinoka T, Ma PX, Shum-Tim D, Breuer CK, Cusick RA, Zund G, et al. Tissue-engineered heart valves autologous valve leaflet replacement study in a lamb model. Circulation.1996;94:II164-8.
10. Shinoka T, Shum-Tim D, Ma PX, Tanel RE, Langer R, Vacanti JP, et al. Tissue-engineered heart valve leaflets: does cell origin affect outcome? Circulation. 1997;96:I102-7.
11. Nakayama Y, Ishibashi-Ueda H, Takamizawa K. In vivo tissue engineered small-caliber arterial graft prosthesis consisting of autologous tissue (Biotube). Cell Transplant. 2004;13:439-49.
12. Lee W, Park BY. The subcutaneous capsules for foreign body in fatal rabbits: preliminary report. Yonsei Med J. 2001;42:595-601.
13. Campbell JH, Efendy J, Campbell GR. Novel vascular graft grown within recipient's own peritoneal cavity. Circ Res. 1999;85:1173-8.
14. Sparks CH. Silicone mandril method of femoropopliteal artery bypass. Clinical experience and surgical technics. Am J Surg. 1972;124:244-9.
15. Hayashida K, Kanda K, Yaku H, Ando J, Nakayama Y. Development of an in vivo tissue-engineered autologous heart valve(the biovalve): preparation of a prototype model. J Thorac Cardiovasc Surg. 2007;134:152-9.
16. Hayashida K, Kanda K, Oie T, Okamoto Y, Ishibashi-Ueda H,Onoyama M, et al. Architecture of an in vivo-tissue engineeredautologous conduit "Biovalve". J Biomed Mater Res B Appl Biomater. 2008;86:1-8.
17. Hayashida K, Kanda K, Oie T, Okamoto Y, Sakai O, Watanabe T, et al. "In vivo tissue-engineered" valved conduit withdesigned molds and laser processed scaffold. J Cardiovasc Nurs.2008;23:61-4.
18. Nakayama Y, Yamanami M, Yahata Y, Tajikawa T, Ohba K,Watanabe T, et al. Preparation of a completely autologous tri-leaflet valve-shaped construct by in-body tissue architecturetechnology. J Biomed Mater Res B Appl Biomater. 2009;91:813-8.
19. Kunzelman KS, Grande KJ, David TE, Cochran RP, Verrier ED. Aortic root and valve relationships. Impact on surgical repair. J Thorac Cardiovasc Surg. 1994;107:162-70.
20. Ohta Y, Kikuta Y, Shimooka T, Mitamura Y, Yuhta T, Dohi T. Effect of the sinus of Valsalva on the closing motion of bileafletprosthetic heart valves. Artif Organs. 2000;24:309-12.
21. Miyazaki T, Yamagishi M, Nakashima A, Fukae K, Nakano T,Yaku H, et al. Expanded polytetrafluoroethylene valved conduitand patch with bulging sinuses in right ventricular outflow tractreconstruction. J Thorac Cardiovasc Surg. 2007;134:327-32
22. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, FaxonDP, Freed MD, et al. ACC/AHA 006 guidelines for the management of patients with valvular heart disease: a report ofthe American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006;48:e1-148.
23. Watanabe T, Kanda K, Ishibashi-Ueda H, Yaku H, Nakayama Y. Autologous small-caliber "biotube" vascular grafts with argatroban loading: a histomorphological examination after implantation to rabbits. J Biomed Mater Res B Appl Biomater. 2010;92:236-12.